Andrew Dudum, CEO of Hims & Hers Health Inc. (NYSE:HIMS), recently sold a significant portion of his holdings in the company.

Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...

Financial writer highlights undervalued Hims & Hers Health with impressive growth potential and innovative product launches, ...

主要风险是， 如果FDA禁止复合GLP-1复合药物的新闻导致股价下跌，即使Hims & Hers Health准确地表示其个性化服务对业务的影响有限，市场也可能轻易忽视其强劲的核心业务， 直到在线健康平台证明GLP-1复合药物业务并非 驱动力 ...

In recent trading, Hims & Hers Health Inc (HIMS) stock price has shown some volatility, fluctuating 9.60% over the last five trades and -10.88% over the past 30 trades. This represents a notable shift ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Hims & Hers Health ( HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth ...

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...

旧金山——根据提交给美国证券交易委员会的文件显示，Hims & Hers Health Inc.（NYSE:HIMS）的首席执行官Andrew Dudum最近出售了他在公司持有的大量股份。Dudum于2025年1月16日以每股26.9639美元至27.3986美元的价格出售了价值约227万美元的股票。

Welcome to this week’s installment of “The Short Interest Report” – The Fly’s weekly recap of short interest trends among some of the most ...

SAN FRANCISCO, December 03, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is proud to announce its inclusion on the Inc. 2024 Best in ...